Key Takeaways From FDA Warnings To CBD Cos.

Key Takeaways From FDA Warnings To CBD Cos. Two warning letters the U.S. Food and Drug Administration recently issued to makers of CBD products highlight the agency’s chief enforcement concerns, but leave some uncertainties regarding the future of CBD regulation, say Kristi Wolff and Donnelly McDowell at Kelley Drye. #CBD #Hemp https://www.law360.com/cannabis/articles/1373589?utm_source=rss&utm_medium=rss&utm_campaign=section April 9, 2021 5:21 pm